Article
ROBO3 is a Potential Prognostic Biomarker that guides treatment option and Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia
2023-04-12
Abstract excerpt
Based on cytogenetic and genetic markers for risk stratification, patients with acute myeloid leukemia (AML) show a very heterogeneous prognosis. Overexpression of ROBO3 has been reported to confer an unfavorable outcome in AML. However, it is unclear whether the prognostic effect of ROBO3 on AML is interfered by treatment option. In this study, we analyzed 148 AML patients with ROBO3 expression information using...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fdfdb92-0beb-5544-9b59-caafef0664bc
- DOI
- 10.21203/rs.3.rs-2767672/v1
